Examkin

Question

Difficulty: MediumMedical Literature and Drug Advertisement Interpretation

An academic peer reviewer is evaluating the methodology section of a manuscript detailing a randomized, double-blind trial for a novel targeted biological therapy in severe eosinophilic asthma. The manuscript contains several specific methodological decisions and statistical observations. Match each excerpted description from the trial to the most accurate biostatistical or epidemiological concept it represents.

  • Participants who failed to receive at least 80% of the scheduled biological injections were excluded from the primary efficacy calculation.Per-protocol analysis
  • The study was powered at 1−β=0.801 - \beta = 0.80 with a one-sided α=0.025\alpha = 0.025 to demonstrate that the novel biologic retains at least 75% of the exacerbation-reduction effect seen with the current standard of care.Non-inferiority testing
  • Because baseline inhaled corticosteroid dosages differed significantly between the treatment arms, investigators employed a multivariate logistic regression model to evaluate the primary outcome.Confounding adjustment
  • Subjects enrolled immediately after a peak exacerbation episode exhibited a natural stabilization in their peak expiratory flow rates during the trial, even in the placebo arm.Regression to the mean

Answer

The descriptions correctly match to: Exclusion of non-compliant patients matches Per-protocol analysis; Powering to retain 75% of active control effect matches Non-inferiority testing; Multivariate regression for baseline differences matches Confounding adjustment; Natural stabilization of extreme baseline values matches Regression to the mean.
Each excerpt distinctly defines a core epidemiological or biostatistical concept required for accurate medical literature interpretation: excluding non-compliers (per-protocol), testing against a margin (non-inferiority), correcting baseline differences (confounding adjustment), and observing natural normalization of extremes (regression to the mean).

Step-by-Step Solution

1
Analyze the handling of non-compliant patients in the first excerpt.
Removing patients missing a percentage of doses matches the concept of 'Per-protocol analysis'.
Per-protocol evaluates ideal efficacy by requiring adherence, unlike intention-to-treat which preserves original randomization.
2
Identify the study design based on the statistical power description and hypotheses.
Demonstrating retention of a specific percentage (75%) of the active control's effect matches 'Non-inferiority testing'.
This establishes a non-inferiority margin to prove the drug is not unacceptably worse than the current standard, rather than testing for strict superiority.
3
Evaluate the purpose of using multivariate regression to account for baseline imbalances.
Correcting for differing baseline corticosteroid use matches 'Confounding adjustment'.
Statistical adjustment is required when randomization fails to evenly distribute known confounding variables, ensuring the outcome difference is due to the drug.
4
Determine the statistical phenomenon occurring when extreme baseline symptoms improve naturally over time.
Natural stabilization after a peak exacerbation episode matches 'Regression to the mean'.
Extreme physiological measurements tend to normalize upon repeated measurement, which can be mistakenly attributed to a treatment effect if not carefully monitored.

Key Concept

Identifying methodological study designs, adjustments, and inherent statistical phenomena in medical literature
Estimated Time:1m 0s
Rate this question

Topics

Medical Literature and Drug Advertisement Interpretation

More questions from this topic